Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Gross Margin (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Gross Margin for 16 consecutive years, with 66.13% as the latest value for Q3 2025.

  • On a quarterly basis, Gross Margin rose 776.0% to 66.13% in Q3 2025 year-over-year; TTM through Sep 2025 was 62.02%, a 114.0% increase, with the full-year FY2024 number at 58.17%, down 258.0% from a year prior.
  • Gross Margin was 66.13% for Q3 2025 at Xtant Medical Holdings, down from 68.58% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 68.58% in Q2 2025 to a low of 50.85% in Q4 2024.
  • A 5-year average of 59.48% and a median of 60.97% in 2023 define the central range for Gross Margin.
  • Peak YoY movement for Gross Margin: crashed -1377bps in 2021, then skyrocketed 776bps in 2025.
  • Xtant Medical Holdings' Gross Margin stood at 55.27% in 2021, then decreased by -2bps to 54.39% in 2022, then grew by 12bps to 60.97% in 2023, then dropped by -17bps to 50.85% in 2024, then soared by 30bps to 66.13% in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Gross Margin are 66.13% (Q3 2025), 68.58% (Q2 2025), and 61.52% (Q1 2025).